20mg/vial

Clinical trials show remarkable average weight loss, exceeding 20-24% of body weight. It helps lower blood sugar, improves insulin sensitivity, and stabilizes energy levels. It effectively reduces fat in the liver, potentially reversing MASH (Metabolic dysfunction-associated steatohepatitis). By targeting multiple pathways, it reduces hunger and cravings, promoting satiety. The glucagon receptor activation boosts calorie burning and metabolism.  Studies suggest improvements in cholesterol, blood pressure, and inflammation, reducing heart risks. Early data indicates it may preserve lean muscle mass better than single-pathway drugs.